Measles Vaccination Supports Millennium Development Goal 4: Increasing Coverage and Increasing Child Survival in Northern Ghana, 1996–2012
Open Access
- 12 February 2018
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 6, 28
Abstract
Background: Measles vaccine (MV) administered as the last vaccine after the third dose of diphtheria-tetanus-pertussis (DTP) may be associated with better child survival unrelated to prevention of measles infection. Other studies have shown that MV administered after DTP was more beneficial and was associated with lower mortality compared with DTP administered after MV or DTP administered simultaneously with MV. We compared the difference in mortality between measles vaccinated after DTP3 and measles-unvaccinated children in Navrongo, Ghana. Methods: This was a follow-up study involving annual cohort of children aged 9-23 months from 1996-2012. We assessed survival in relation to the measles vaccination status within the first 12 months from interview date and until five years of age using Cox proportional hazards models. Results: In all, 38,333 children were included in the study. The proportion of children vaccinated with MV after DTP3 increased from 45% in 1996 to 95% in 2012. The adjusted hazard ratio (HR) for measles unvaccinated compared with MV-after-DTP3 vaccinated children was 1.38(1.15-1.66) in the first 12 months after assessment of vaccination status and 1.22(1.05-1.41) with follow-up to five years of age. The national immunization days (NID) campaigns with Oral Polio Vaccine (OPV) or MV might have reduced the effect of being MV-after-DTP3 vaccinated versus MV-unvaccinated. For 12 months of follow-up, the HR before a campaign for MV-unvaccinated children was 1.63(1.23-2.17) compared to those who received MV-after-DTP3. After the campaign, the HR reduced to 1.23(0.97-1.54). Stratifying the analysis by sex, measles unvaccinated boys had a hazard ratio of 1.69(1.33-2.61) compared to measles unvaccinated girls who had a hazard ratio 1.06(0.79-1.40) during one year follow-up. In 1989, only 7% of children in the area had received MV-after-DTP3; the increase in MV-after-DTP3 coverage from 1989 to 2012 may have lowered mortality rate among children aged 9 months to 3 years by 24%. Conclusion: Though an observational study, our findings suggest that measles vaccination, administered in the recommended sequence, is associated with improved child survival and may have contributed importantly to the mortality decline towards the achievement of MDG4.Keywords
Funding Information
- Danida Fellowship Centre (104.Dan.8-920)
- Seventh Framework Programme (Health-F3-2011-261375)
This publication has 42 references indexed in Scilit:
- A small jab – a big effect: nonspecific immunomodulation by vaccinesTrends in Immunology, 2013
- Non-specific and sex-differential effects of vaccinations on child survival in rural western IndiaVaccine, 2012
- Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytesProceedings of the National Academy of Sciences, 2012
- Reduction in child mortality in Niger: a Countdown to 2015 country case studyThe Lancet, 2012
- Testing the hypothesis that diphtheria–tetanus–pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countriesBMJ Open, 2012
- Ten years of the Global Alliance for Vaccines and Immunization: challenges and progressNature Immunology, 2010
- Rapid achievement of the child survival millennium development goal: evidence from the Navrongo experiment in Northern GhanaTropical Medicine & International Health, 2007
- Sex Differential Effects of Routine Immunizations and Childhood Survival in Rural MalawiThe Pediatric Infectious Disease Journal, 2006
- Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa.. Kristensen I, Aaby P and Jensen H (2000) British Medical Journal, 321: 1435.Ambulatory Child Health, 2001
- INFLUENCE OF MEASLES VACCINATION ON SURVIVAL PATTERN OF 7-35-MONTH-OLD CHILDREN IN KASONGO, ZAIREThe Lancet, 1981